AMNEAL PHARMACEUTICALS INC (AMRX) Stock Analyst Earnings Estimates
NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.212B 5.67% | 2.394B 8.20% | 2.794B 16.73% | 3.071B 9.92% | 3.298B 7.39% | 3.575B 8.40% | 2.826B -20.95% | 2.912B 3.04% | 3.002B 3.09% | |
| EBITDA YoY % growth | 439.477M -2.30% | 504.247M 14.74% | 584.564M 15.93% | 680.07M 16.34% | 730.18M 7.37% | 823.1M 12.73% | 706.55M -14.16% | 738.68M 4.55% | 773.36M 4.69% | |
| EBIT YoY % growth | 199.302M -7.90% | 274.847M 37.90% | 348.373M 26.75% | 560.67M 60.94% | 606.86M 8.24% | 752.14M 23.94% | 433.6M -42.35% | 444.01M 2.40% | 455.02M 2.48% | |
| Operating Margin | 9.01% | 11.48% | 12.47% | 18.26% | 18.40% | 21.04% | 15.34% | 15.25% | 15.16% | |
| EPS YoY % growth | 0.68 -19.05% | 0.64 -5.88% | 0.58 -9.37% | 0.72 23.98% | 0.84 17.38% | 1.05 24.07% | 0.94 -10.39% | 1.02 8.70% | 1.11 9.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.18 11.56% | 0.16 29.63% | 0.17 -17.43% |
| Revenue Q2Q % growth | 795.25M 13.21% | 801.94M 9.78% | 765.13M 10.02% |
| EBITDA Q2Q % growth | 172.05M -33.54% | 164.47M -47.66% | 169.21M 5.05% |
| EBIT Q2Q % growth | 143.37M 61.39% | 131.84M 68.88% | 127.89M 26.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.25 56.25% | 0.18 | 0.07 | 40.06% |
| Q1 2025 Q2Q % growth | 0.21 50.00% | 0.15 | 0.06 | 40.37% |
| Q4 2024 Q2Q % growth | 0.12 -14.29% | 0.16 | -0.04 | -22.85% |
| Q3 2024 Q2Q % growth | 0.16 -15.79% | 0.14 | 0.02 | 16.19% |
| Q2 2024 Q2Q % growth | 0.16 -15.79% | 0.14 | 0.02 | 13.26% |
| Q1 2024 Q2Q % growth | 0.14 16.67% | 0.09 | 0.05 | 49.19% |
| Q4 2023 Q2Q % growth | 0.14 -39.13% | 0.09 | 0.05 | 52.17% |
| Q3 2023 Q2Q % growth | 0.19 35.71% | 0.13 | 0.06 | 46.90% |
| Q2 2023 Q2Q % growth | 0.19 | 0.11 | 0.08 | 75.73% |
| Q1 2023 Q2Q % growth | 0.12 | 0.10 | 0.02 | 22.55% |
| Q4 2022 Q2Q % growth | 0.23 27.78% | 0.21 | 0.02 | 7.74% |
| Q3 2022 Q2Q % growth | 0.14 -33.33% | 0.18 | -0.04 | -22.39% |
| Q2 2022 Q2Q % growth | 0.19 -24.00% | 0.20 | -0.01 | -4.13% |
| Q1 2022 Q2Q % growth | 0.12 -40.00% | 0.13 | -0.01 | -9.01% |
| Q4 2021 Q2Q % growth | 0.18 28.57% | 0.20 | -0.02 | -11.26% |
| Q3 2021 Q2Q % growth | 0.21 31.25% | 0.21 | 0.00 | 0.78% |
| Q2 2021 Q2Q % growth | 0.25 92.31% | 0.19 | 0.06 | 33.39% |
| Q1 2021 Q2Q % growth | 0.20 | 0.18 | 0.02 | 11.18% |
| Q4 2020 Q2Q % growth | 0.14 75.00% | 0.14 | 0.00 | 2.01% |
| Q3 2020 Q2Q % growth | 0.16 300.00% | 0.12 | 0.04 | 28.77% |
| Q2 2020 Q2Q % growth | 0.13 44.44% | 0.10 | 0.03 | 31.84% |
| Q1 2020 Q2Q % growth | 0.20 42.86% | 0.09 | 0.11 | 120.09% |
| Q4 2019 Q2Q % growth | 0.08 | 0.05 | 0.03 | 55.16% |
| Q3 2019 Q2Q % growth | 0.04 | 0.14 | -0.10 | -71.42% |
| Q2 2019 Q2Q % growth | 0.09 | 0.14 | -0.05 | -35.04% |
| Q1 2019 Q2Q % growth | 0.14 | 0.18 | -0.04 | -22.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 724.51M 3.24% | 759.45M | -34.94M | -4.60% |
| Q1 2025 Q2Q % growth | 695.42M 5.50% | 729.8M | -34.38M | -4.71% |
| Q4 2024 Q2Q % growth | 730.518M 18.40% | 721.7M | 8.818M | 1.22% |
| Q3 2024 Q2Q % growth | 702.468M 13.29% | 710.73M | -8.262M | -1.16% |
| Q2 2024 Q2Q % growth | 701.78M 17.15% | 671.3M | 30.48M | 4.54% |
| Q1 2024 Q2Q % growth | 659.191M 18.23% | 631.41M | 27.781M | 4.40% |
| Q4 2023 Q2Q % growth | 616.98M 1.18% | 646.91M | -29.93M | -4.63% |
| Q3 2023 Q2Q % growth | 620.04M 13.65% | 607.18M | 12.86M | 2.12% |
| Q2 2023 Q2Q % growth | 599.046M 7.10% | 576.72M | 22.326M | 3.87% |
| Q1 2023 Q2Q % growth | 557.54M 12.04% | 548.05M | 9.49M | 1.73% |
| Q4 2022 Q2Q % growth | 609.759M 13.57% | 591.51M | 18.249M | 3.09% |
| Q3 2022 Q2Q % growth | 545.557M 3.21% | 573.1M | -27.543M | -4.81% |
| Q2 2022 Q2Q % growth | 559.355M 4.54% | 547.06M | 12.295M | 2.25% |
| Q1 2022 Q2Q % growth | 497.633M 0.92% | 514.05M | -16.417M | -3.19% |
| Q4 2021 Q2Q % growth | 536.896M 5.27% | 548.1M | -11.204M | -2.04% |
| Q3 2021 Q2Q % growth | 528.593M 1.79% | 555.97M | -27.377M | -4.92% |
| Q2 2021 Q2Q % growth | 535.075M 15.14% | 533.71M | 1.365M | 0.26% |
| Q1 2021 Q2Q % growth | 493.1M -1.08% | 523.5M | -30.4M | -5.81% |
| Q4 2020 Q2Q % growth | 510M 28.37% | 517.16M | -7.16M | -1.38% |
| Q3 2020 Q2Q % growth | 519.3M 37.27% | 491.75M | 27.55M | 5.60% |
| Q2 2020 Q2Q % growth | 464.7M 14.85% | 466.41M | -1.71M | -0.37% |
| Q1 2020 Q2Q % growth | 498.5M 11.75% | 455.04M | 43.46M | 9.55% |
| Q4 2019 Q2Q % growth | 397.3M | 402.68M | -5.38M | -1.34% |
| Q3 2019 Q2Q % growth | 378.3M | 417.16M | -38.86M | -9.32% |
| Q2 2019 Q2Q % growth | 404.6M | 437.15M | -32.55M | -7.45% |
| Q1 2019 Q2Q % growth | 446.1M | 447.54M | -1.44M | -0.32% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.94% | -2.78% | -0.24% | 3.68% |
| Revenue | -1.17% | -2.64% | 0.07% | -0.52% |